Connect with us

Cannabis News

“Our members are united and ready to do whatever it takes to secure a strong contract”

Published

6 hours ago

on






The Pennsylvania Teamsters open strike






Union workers at the Sunnyside dispensary in Wyomissing have voted unanimously to authorize a strike after the company failed to present a contract that adequately compensates workers. Sunnyside is a subsidiary of Cresco Labs, a public multi-state operator in the cannabis industry.

“Our members are united and ready to do whatever it takes to get a strong contract,” said Bill Shappell, president of Teamsters Local 429. “Sunnyside is part of a rapidly growing industry, and these workers are vital to the company’s success. They will not accept wages and working conditions that fall short of the standards they deserve.”

© International Brotherhood of Teamsters

The Cannabis Teamsters of Sunnyside are fighting for fair wages and better working hours. The strike highlights the Teamsters’ growing power in the cannabis industry and follows another work stoppage in November, when the Pennsylvania Teamsters won the most successful cannabis strike in US history.

“The Teamsters are building pathways for cannabis workers to support their families and enjoy a middle-class lifestyle,” said Jesse Case, director of the Teamsters Food Processing Division. “In many other industries, people in this country can start young and build careers that last for decades. There’s no reason cannabis workers should want or expect anything less.”

“We want to set a quality standard for working in the cannabis industry by ensuring fair wages and promoting long-term careers,” said Cobi Motley, a Sunnyside wellness consultant and Local 429 member. “We cannot accept a contract that creates economic instability in our future. It’s time for business to come back to the table and offer fair treatment.”

For more information:
International Brotherhood of Teamsters
teamster.org/



Publication date:













Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis News

Indiana Won’t Ban Hemp THC Products This Year After Last-Minute Legislative Push Fails

Published

6 hours ago

on

February 28, 2026

By

A backer of the ban on THC products complained that lawmakers would end the session “without doing anything” about hemp.

By Leslie Bonilla Muniz, Indiana Capital Chronicle

Indiana bans synthetic and intoxicating drugs derived from hemp he was dead for less than a week before he was resurrected and died again—this time, at least until the next year.

Indiana will go another year without a 21-plus age limit on intoxicating hemp products, Sen. Aaron Freeman, R-Indianapolis, complained Friday.

Lawmakers have tried time and time again regulate delta-8, TCHA and other powerful cannabinoid productswho have been in a legal gray area for eight years. THC is the active ingredient in marijuana, which remains banned at the federal level and in the Hoosier State.

Indiana’s efforts have consistently failed amid House and Senate gridlock over how expansive or restrictive the state’s vision should be.

Freeman’s Senate Bill 250 took a tougher tone, reflecting Congress’ closing of a so-called loophole in the 2018 Farm Bill. That law defined legal hemp as any part of the plant containing less than 0.3 percent delta-9 THC by dry weight, sparking a booming industry of other intoxicating cannabinoids.

A federal funding law passed in November specifies that all types of THC count. It also limits THC products to just 0.4 milligrams per container, and completely bans those made in labs. It will come into effect next November.

Freeman said lawmakers would end the legislative session “doing nothing” about hemp, leaving the state statute inconsistent with the federal one. The Supremacy Clause of the US Constitution says that federal law wins over conflicting state codes, but Freeman was still concerned.

“Right now, marijuana is illegal, (but) tell that to any state that has legalized it. Don’t tell that to California; they don’t care,” he said. “So they’re saying we’re not following federal law. Now, I think that’s a really dangerous precedent. … And by the way, Indiana is going to be in that category in November, and that’s scary to me.”

The Indiana bill also established a regulatory scheme for any low-wattage product on the market, notably with a long-standing age requirement.

Industry representatives previously testified that customers would not want THC products that do not produce the drug. The legislation would not affect CBD, which is not intoxicating.

It cleared the committee stage and then passed the Senate on a 35-15 vote. The bill reached the House floor but was not called for second reading before a key deadline on Monday.

“Another example of what we need to have a unicameral Legislature,” he told the Capital Chronicle at the time.

Legislators from the four groups met in conference committee on Thursday to unveil plans for the divestment. Senate Bill 144 incorporating its provisions and the Senate-passed version of Freeman’s bill. But he was not on the conference committee the report He was released on Friday afternoon.

Rep. Elizabeth Rowray, R-Yorktown, said it was the third version of the CCR and acknowledged that the hemp drug ban was “added” and “was later removed.”

Indiana is among 10 states that do not allow the sale of medicinal and recreational herbs. The state has stubbornly resisted efforts to legalize marijuana—even the Republicans.

President Donald Trump signed an executive order in December to reclassify marijuana as a less dangerous drug, but that hasn’t been finalized yet.

This story was first published by the Indiana Capital Chronicle.

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

New rules raise cannabis stock limits for Malta’s associations

Published

1 day ago

on

February 27, 2026

By











Malta’s cannabis associations will be able to hold larger stocks of cannabis under new rules introduced last week. While associations were previously only allowed to keep 500g of cannabis, a new legal notice sets different limits depending on the number of members registered with each.

Malta’s largest cannabis associations, with over 350 members, will now be able to sell 3.5kg of cannabis. Between 250 and 350 members will be allowed to possess 2.45 kg of cannabis, and associations registering between 110 and 250 members will be allowed to possess up to 1.75 kg.

Smaller ones will have stricter limits. Associations with less than 100 members will only have 700 g, while those with less than 50 members will have 350 g. Meanwhile, associations are allowed to store the equivalent of an eight-month supply in their cultivation area, calculated at 50g per member.

The new rules do not change how much cannabis a person can carry or consume. Under Malta’s cannabis laws, first introduced at the end of 2021, people can carry up to 7g of cannabis without fear of prosecution. Anyone caught with between 7g and 28g of cannabis will appear in court rather than face charges in a criminal court.

Read more at Maltese times










Continue Reading

Cannabis News

Trump Administration ‘Very Anxious’ To Allow Psychedelic Therapy ‘As Quickly As Possible,’ RFK Tells Joe Rogan

Published

1 day ago

on

February 27, 2026

By

The Trump administration is “very eager” to create a pathway for access to psychedelic therapy, Robert F. Kennedy Jr. According to the secretary of the US Department of Health and Human Services (HHS), and senior officials of federal agencies want to “communicate to the public as soon as possible.”

In an interview on the Joe Rogan Experience podcast released Friday, Kennedy said he’s confident “we’re going to get it,” with plans to develop and finalize rules that would allow patients with conditions like post-traumatic stress disorder (PTSD) and depression to access psychedelic substances like psilocybin and MDMA in a “very controlled environment.”

The secretary has been noted for his advocacy of psychedelic reform, an idea he floated as a 2024 Democratic presidential candidate before ultimately becoming the nation’s top health official under the Trump administration.

The president himself has been silent on the issue, but as Kennedy points out, support for expanding access to research and new therapeutics extends beyond HHS, with the heads of the US Department of Veterans Affairs (VA), the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) also looking to take advantage of the potential benefits of psychedelic drugs.




“Everybody in my agency, and in (Secretary Doug Collins’) agency at the VA, is very eager to get a rule that will allow these types of studies and allow them to go into therapeutic settings, particularly for military personnel who have suffered these injuries to have access to these products,” Kennedy said. “We are working on that process now. We are all working and trying to make it happen.”

“I think we’ll make it.”

While some of the reform proposals being considered would be designed to “encourage more clinical trials” while having “very strong guidelines,” the health secretary said the agencies are interested in the full range of options that could include psychedelic therapies and other “rapid interventions.” One of Kennedy’s personal goals would be to validate the utility of substances like psilocybin over SSRIs for depression.

“We’re looking at that as a whole category of interventions that people should be able to look at and have appropriate access to, and we should roll it out as quickly as possible,” he said.

“This is what we’re anticipating, so I can’t tell you exactly what we’re going to do, but very, very strong therapeutic guidelines, so how they’re applied, what kind of follow-up. Because a lot of these things rewire the brain. If you don’t follow-up, it doesn’t work, or you have a failure rate. So we’re developing all of those things and I think we’re developing protocols. People in the administration are eager to do that as soon as possible. I know Doug Collins is doing 21 studies at the VA that they are doing, that they are very promising.

“You need those guidelines because you don’t want to do the Wild West. You can have horror stories overnight because some people can have very, very bad experiences,” Kennedy said. “We’re looking at ways to do it so it’s in a very controlled environment.”

Asked to expand on how Rogan sees the future of psychedelic therapies and whether it will include people in the military or other non-frontline roles, the secretary said he would “personally” like to see broad access, but “we have to take baby steps because you don’t want to create a situation where people want to get hurt.”

However, “you shouldn’t have a soldier who has given everything for the country, who has suffered terribly, who has come to Tijuana to receive these treatments, leave our country to receive treatments,” he said. “It doesn’t make sense.”

“I’ve seen so much overwhelming anecdotal evidence,” Kennedy said, emphasizing that one of his relatives has benefited from psychedelic therapy“but also clinical studies that verify the effect.” And officials at agencies like the NIH and FDA are “doing everything they can to make that happen.”

Rogan’s podcast interview comes a month after the release of a book by a reporter who allegedly had a romantic relationship with Kennedy, in which, as a presidential candidate, Kennedy still used psychedelics like DMT for “fun” and hid his drug use from his wife.

Meanwhile, in November, Kennedy, Vice President JD Vance, FDA Commissioner and other Trump administration officials attended the “Make America Healthy Again” summit. it was a session dedicated to studying psychedelic medicine.

In June, Kennedy said that his agency “Fully committed” to expanding research into the benefits of psychedelic therapy. and, along with the head of the FDA, aims to give military veterans legal access to these substances “within 12 months.”

The secretary also said that in April He had a “wonderful experience” with LSD at the age of 15He took it because he thought they would be able to see dinosaurs, as depicted in a comic he was a fan of.

Last October, Kennedy specifically criticized the FDA under the previous administration for the agency’s “eradication of psychedelics” and a laundry list of other issues that he said was a “war on public health” that would end under the Trump administration.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media